CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose in 12-18 Months Old Healthy Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01171989
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:26.737660+00:00
Published At: 2017-04-11T00:00:00+00:00
Record Updated At: 2020-01-21
Results Posted At: 2017-04-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tetanus", "Diphtheria", "Haemophilus Influenzae Type b", "Hepatitis B", "Poliomyelitis", "Acellular Pertussis", "Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-01-21"
protocolSection.identificationModule.nctId: "NCT01171989"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety Study of GlaxoSmithKline Biologicals\u0027 GSK2202083A Vaccine Administered as a Booster Dose in 12-18 Months Old Healthy Children"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-04-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.